title: Lymphangiogenesis and its correlation with the VEGF expression and the sentinel lymph node in cutaneous melanomas.
abstract: The aim of the study is to evaluate the density of intratumoral and peritumoral lymphatic vessels in primary cutaneous melanomas and to assess their correlation with the status of sentinel lymph nodes and the VEGF expression in tumor cells and stromal cells. A total of 40 patients were enrolled in the study: the melanomas were radically excised with the extirpation of the sentinel lymph node. The study subjects were divided into two groups: 20 cases with positive and 20 cases with negative sentinel lymph node results. The density of lymphatic vessels was evaluated by the antibody D2-40 and the VEGF expression was investigated in the semiquantitative way. The VEGF expression in melanoma cells and the stromal cells was negative to variable positive at both SLN negative and SLN positive patients in all pT stages. In the group of SLN positive patients, the density of intratumoral lymphatic vessels was low up to moderate, while it was observed to be absent, somewhere on the low level in the group of SLN negative patients. On the other side, the density of peritumoral lymphatic vessels was equally numerous at both SLN negative and SLN positive patients. The lymphatic invasion was found out at 4 SLN positive patients only. The ulceration was chiefly in the group of LN positive patients. The results show that the density of lymphangiogenesis and the intensity of the VEGF expression are considered to be an unreliable predictor of melanoma metastasis to the sentinel lymph node, but the ulceration and the lymphatic invasion can predict the potential for metastasis.
authors.affiliation: Department of Pathology, Faculty Hospital, Ostrava, Czech Republic.
authors.forename: Petr
authors.initials: P
authors.lastname: Buzrla
authors.affiliation: Department of Pathology, Faculty Hospital, Ostrava, Czech Republic ; Institute of Pathology, School of Medicine, University of Ostrava, Ostrava, Czech Republic.
authors.forename: Jana
authors.initials: J
authors.lastname: Dvorackova
authors.affiliation: Center of Nanotechnology, VSB-Technical University, Ostrava, Czech Republic.
authors.forename: Oldrich
authors.initials: O
authors.lastname: Motyka
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology*; D042583:Lymphangiogenesis / Q000502:physiology*; D008207:Lymphatic Metastasis; D008297:Male; D008545:Melanoma / Q000378:metabolism* / Q000473:pathology; D008875:Middle Aged; D012878:Skin Neoplasms / Q000378:metabolism* / Q000473:pathology; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*
chemical_list: C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A
references.citation: Semin Oncol. 2007 Dec;34(6):555-65
references.pmid: 18083379
references.citation: J Clin Pathol. 2005 Jul;58(7):715-21
references.pmid: 15976338
references.citation: J Clin Pathol. 2006 Feb;59(2):166-73
references.pmid: 16443733
references.citation: Br J Cancer. 1997;76(7):930-4
references.pmid: 9328154
references.citation: Cancer Cell. 2009 Mar 3;15(3):220-31
references.pmid: 19249680
references.citation: Anat Rec (Hoboken). 2008 Oct;291(10):1227-35
references.pmid: 18561194
references.citation: J Clin Oncol. 2002 Apr 1;20(7):1826-31
references.pmid: 11919240
references.citation: Mod Pathol. 2005 Sep;18(9):1232-42
references.pmid: 15803182
references.citation: N Engl J Med. 1971 Nov 18;285(21):1182-6
references.pmid: 4938153
references.citation: Histopathology. 2008 Mar;52(4):500-9
references.pmid: 18315603
references.citation: J Exp Med. 2005 Apr 4;201(7):1089-99
references.pmid: 15809353
references.citation: Virchows Arch. 2011 May;458(5):621-30
references.pmid: 21279519
references.citation: Virchows Arch. 2008 Sep;453(3):257-65
references.pmid: 18679715
references.citation: Exp Cell Res. 2006 Mar 10;312(5):549-60
references.pmid: 16336962
references.citation: Histopathology. 2005 Aug;47(2):186-94
references.pmid: 16045780
references.citation: Cancer. 2002 Nov 1;95(9):1963-70
references.pmid: 12404291
references.citation: J Leukoc Biol. 2006 Oct;80(4):691-6
references.pmid: 16793912
references.citation: Mod Pathol. 2009 Jan;22(1):21-30
references.pmid: 18660796
references.citation: Nat Med. 2003 Jun;9(6):669-76
references.pmid: 12778165